Natalie W. Pursell

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria

Cheng-Jung Lai, Natalie W. Pursell, Jessica J. Gierut et al. · Molecular Therapy · 2018 · 106 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion

Jing Wang, Natalie W. Pursell, Maria Samson et al. · Molecular Cancer Therapeutics · 2013 · 83 citations

Medicine, Oncology, Pharmacology +17

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1

Chaitali Dutta, Nicole Avitahl-Curtis, Natalie W. Pursell et al. · Molecular Therapy · 2016 · 83 citations · Full text

Life Sciences, Biochemistry, Molecular Genetics +15

Hepatocyte mARC1 promotes fatty liver disease

Lara C. Lewis, Lingyan Chen, L. Shahul Hameed et al. · JHEP Reports · 2023 · 38 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases

Natalie W. Pursell, Jessica J. Gierut, Wei Zhou et al. · Molecular Therapy · 2018 · 33 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17